Use your antibodies-online credentials, if available.
抗Mouse (Murine) 抗体:
抗Rat (Rattus) 抗体:
Human Polyclonal XYLT1 Primary Antibody for EIA, WB - ABIN955606
Müller, Prante, Kleesiek, Götting: Identification and characterization of the human xylosyltransferase I gene promoter region. in The Journal of biological chemistry 2009
Show all 5 references for 955606
Human Polyclonal XYLT1 Primary Antibody for IHC, IHC (p) - ABIN4366482
McCoy, Falgowski, Srinivasan, Thompson, Selva, Kirn-Safran: Serum xylosyltransferase 1 level increases during early posttraumatic osteoarthritis in mice with high bone forming potential. in Bone 2012
Notch (显示 NOTCH1 抗体)-modifying xylosyltransferase structures support an SNi-like retaining mechanism.
We show that the pug (显示 MTHFD1 抗体) mutation disrupts Xylt1 activity and subcellular localization, leading to a reduction in GAG chains in pug (显示 MTHFD1 抗体) mutants. The pug (显示 MTHFD1 抗体) mutant serves as a novel model for mammalian dwarfism.
Novel and recurrent XYLT1 mutations in two Turkish families with Desbuquois dysplasia, type 2, have been reported.
Our study describes the first case of DBQD2 resulting from compound heterozygous XYLT1 mutation, expands the mutational spectrum of the disease and provides evidence that the severe growth retardation and microsomia observed in DBQD2 patients may result not only from the skeletal dysplasia itself but also from GH and IGF-1 (显示 IGF1 抗体) deficiency.
XYLT1 mutation is associated with short limb skeletal dysplasia.
Human XYLT1 promoter sequence analysis and description.
These results suggest that XT-1 expression is refractory to the disease process and to inhibition by inflammatory cytokines and that signaling through AP-1, Sp1, and Sp3 is important in the maintenance of XT-1 levels in NP cells.
five distinct homozygous XYLT1 mutations may have a role in Desbuquois dysplasia type 2
A family study shows that functional alterations of XYLT1 cause an autosomal recessive short stature syndrome associated with intellectual disability.
XYLT1 activity increased time-dependently in response to progressive myofibroblast transformation.
AP-1 (显示 FOSB 抗体) and Sp3 (显示 SP3 抗体) are key regulators of IL-1beta (显示 IL1B 抗体)-mediated modulation of xylosyltransferase I expression.
Xylosyltransferase-I regulates glycosaminoglycan synthesis during the pathogenic process of human osteoarthritis
This locus encodes a xylosyltransferase enzyme. The encoded protein catalyzes transfer of UDP-xylose to serine residues of an acceptor protein substrate. This transfer reaction is necessary for biosynthesis of glycosaminoglycan chains. Mutations in this gene have been associated with increased severity of pseudoxanthoma elasticum.
UDP-D-xylose:core protein beta-D-xylosyltransferase
, xylosyltransferase I
, peptide O-xylosyltransferase 1
, O-xylosyltransferase 1
, beta-D-xylosyltransferase 1
, xylosyltransferase 1
, xylosyltransferase iota
, protein xylosyltransferase